Snake give us a link. Even if true I highly doubt that oppenheimer has clue what the FDA is thinking. Like it or not this also is a breakthrough drug for the 13% of kids with the mutation at 51. Keep in mind that they have Phase 1 studies for other genomes that affect more kids than those at 51. Also look at the latest set a slides that show the increased dystrophin on biopsy. That is real hard data not someone that is speculating and probably has less than a working knowledge of the of the mundane but intricate aspect of the studies. Get over it man this a first time these familes have real hope backed up by pathology.